[Form 4] Atlassian Corporation Insider Trading Activity
Rhea-AI Filing Summary
Atlassian (TEAM) director and 10% owner Scott Farquhar reported multiple open-market sales of Class A common stock executed on 08/26/2025 under a Rule 10b5-1 trading plan adopted on 02/12/2025. The Form 4 shows six separate sales totaling 7,665 shares at weighted-average prices ranging from about $164.56 to $169.64, with the reported weighted-average prices per tranche noted on the form. After these transactions, beneficial ownership attributed to Farquhar (held via Farquhar Investment Partnership No. 2) is reported as 183,960 shares. The filer certified willingness to provide detailed trade-by-trade prices and quantities upon request.
Positive
- None.
Negative
- Director sold 7,665 Class A shares in open-market transactions on 08/26/2025 under a 10b5-1 plan
- Post-transaction indirect beneficial ownership declined to 183,960 shares held via Farquhar Investment Partnership No. 2
Insights
TL;DR: A controlling insider executed preplanned sales under a 10b5-1 plan; disclosure is routine but notable given director's large ownership.
The filing documents routine, Rule 10b5-1-plan-driven sales by a founder-level director who is also a reported 10% owner. The transactions are clearly disclosed with weighted-average prices and an explicit offer to supply detailed trade data on request, which supports regulatory transparency. Because the shares are held indirectly via an investment partnership, the Form correctly identifies indirect beneficial ownership and shows the post-sale holding. This is a governance-level liquidity event, not a compensatory grant or unusual transaction.
TL;DR: Insider sold 7,665 TEAM shares across price bands ~$164–$169; post-sale indirect holdings stand at 183,960 shares.
The transactions were executed in multiple trades across six tranches with reported weighted-average prices per tranche between roughly $164.00 and $169.64. The aggregate sale size (7,665 shares) and the post-transaction indirect ownership (183,960 shares) are explicitly reported. The sales were effected under a 10b5-1 plan adopted 02/12/2025, indicating prearranged timing rather than discretionary trading on the reported date.